LAKEWOOD, Colo., Feb. 16, 2023 /PRNewswire/ -- Today, Terumo Blood and Cell Technologies announces U.S. Food and Drug Administration (FDA) clearance and official launch of its IMUGARD ® WB Platelet ...
This was a prospective randomized control study of 43 platelet transfusions given to newborns. Transfusions were randomized to run over either 30 min or 2 h. Platelet counts taken 30 min and 6 h after ...
Please provide your email address to receive an email when new articles are posted on . Variations in donor platelet function did not affect the outcome of prophylactic transfusions among patients ...
Effect of Splenectomy on the Response to Platelet Transfusion in Three Patients with Aplastic Anemia
THE variability in the natural history of both acquired and idiopathic aplastic anemia makes it difficult to evaluate the success of any specific program of therapy. With careful attention to ...
Terumo Blood and Cell Technologies has announced US Food and Drug Administration (FDA) clearance and official launch of its IMUGARD(R)WB Platelet Pooling Set, which supports extended shelf life of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results